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Phthalates are a class of high-production-  volume 
chemicals widely used in consumer products 
(Sathyanarayana 2008). Biomonitoring studies 
have established unequivocally that exposures 
in the United States are ubiquitous [Centers 
for Disease Control and Prevention (CDC) 
2011]. Concentrations of certain phthalates 
in maternal urine during pregnancy have been 
associated with adverse child cognitive and/
or behavioral development (Engel et al. 2010; 
Miodovnik et al. 2011; Swan et al. 2010). 
Cross-sectional studies report associations 
between phthalate metabolites in children’s 
urine and behavioral problems and reduced 
IQ postnatally (Cho et al. 2010; Kim et al. 
2009). Experimental research is limited but has 
shown adverse effects of prenatal exposure of 
rats to di-2-ethylhexyl phthalate (DEHP) and 
di-n-butyl phthalate (DnBP) on pup learning, 
memory, and behavior (Arcadi et al. 1998; Li 
et al. 2009; Tanaka 2002, 2005).
Phthalates have short biological half-lives, 
with most metabolites eliminated within 
24 hr (Wittassek and Angerer 2008). Once 
absorbed, phthalates are rapidly metabolized 
into monoesters, and some monoesters can 
undergo further transformations into more 
hydrophilic oxidative metabolites; metabolites 
are eliminated mainly in urine (Heudorf et al. 
2007). Epidemiologic studies measure phtha-
late metabolites in urine as internal dosimeters 
of exposure because urinary enzymatic activ-
ity is negligible and most of the metabolites 
present arise from elimination of endogenous 
phthalates, rather than from external contami-
nation with phthalates during collection and 
processing. The aim of the present study was 
to evaluate the association between child men-
tal, psychomotor, and behavioral development 
after prenatal exposures to four phthalates: 
DnBP, diisobutyl phthalate (DiBP), butyl-
benzyl phthalate (BBzP), and DEHP.
Materials and Methods
We selected 319 pregnant inner-city women 
who delivered between 1999 and 2006 from 
the longitudinal birth cohort of 727   mothers 
and newborns being conducted by the 
Columbia Center for Children’s Environmental 
Health (CCCEH). Enrollment and exclusion 
criteria have been described previously (Perera 
et al. 2003). The CCCEH cohort was restricted 
to non  smoking women 18–35 years of age 
who self-identified as either African American 
or Dominican and who had resided in north-
ern Manhattan or the South Bronx in New 
York City for at least 1 year before pregnancy. 
Women were excluded if they used illicit drugs, 
had diabetes, hypertension, or known HIV, 
or had their first prenatal visit after the 20th 
week of pregnancy. The study was approved by 
the Columbia University Medical Center and 
CDC institutional review boards (IRBs). Study 
procedures were explained at enrollment, and 
each woman signed an IRB-approved consent 
form. We selected women (n = 319) for partici-
pation in the present study if phthalate metabo-
lite concentrations had been measured in spot 
urine samples collected during pregnancy, if 
the child had completed the Bayley Scales of 
Infant Development II (BSID-II; n = 297) or 
the mother had completed the Child Behavior 
Checklist (CBCL; n = 286) at the child age 
3–year visit, and data were available on model 
covariates. The 319 subjects did not differ sig-
nificantly from the remaining subjects in the 
CCCEH cohort in terms of basic demograph-
ics (race/ethnicity, maternal prenatal marital 
status and education level, household income, 
proportion on Medicaid or other public assis-
tance) or on child sex, gestational age, and birth 
weight (all p-values > 0.05).
Questionnaire and medical record data. 
A trained bilingual interviewer administered 
a 45-min questionnaire to each woman in her 
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Ba c k g r o u n d: Research suggests that prenatal phthalate exposures affect child executive function 
and behavior.
oB j e c t i v e: We evaluated associations between phthalate metabolite concentrations in maternal 
prenatal urine and mental, motor, and behavioral development in children at 3 years of age.
Me t h o d s : Mono-n-butyl phthalate (MnBP), monobenzyl phthalate (MBzP), monoisobutyl 
phthalate (MiBP), and four di-2-ethylhexyl phthalate metabolites were measured in a spot urine 
sample collected from 319 women during the third trimester. When children were 3 years of age, 
the Mental Development Index (MDI) and Psychomotor Development Index (PDI) were measured 
using the Bayley Scales of Infant Development II, and behavior problems were assessed by maternal 
report on the Child Behavior Checklist.
re s u l t s: Child PDI scores decreased with increasing loge MnBP [estimated adjusted β-coefficient 
= –2.81; 95% confidence interval (CI): –4.63, –1.0] and loge MiBP (β = –2.28; 95% CI: –3.90, 
–0.67); odds of motor delay increased significantly [per loge MnBP: estimated adjusted odds ratio 
(OR) = 1.64; 95% CI: 1.10, 2.44; per loge MiBP: adjusted OR =1.82; 95% CI: 1.24, 2.66]. In girls, 
MDI scores decreased with increasing loge MnBP (β = –2.67; 95% CI: –4.70, –0.65); the child sex 
difference in odds of mental delay was significant (p = 0.037). The ORs for clinically withdrawn 
behavior were 2.23 (95% CI: 1.27, 3.92) and 1.57 (95% CI: 1.07, 2.31) per loge unit increase in 
MnBP and MBzP, respectively; for clinically internalizing behaviors, the OR was 1.43 (95% CI: 
1.01, 1.90) per loge unit increase in MBzP. Significant child sex differences were seen in associations 
between MnBP and MBzP and behaviors in internalizing domains (p < 0.05).
co n c l u s i o n: Certain prenatal phthalate exposures may decrease child mental and motor develop-
ment and increase internalizing behaviors.
key w o r d s : behavior, child, mental, phthalates, prenatal, psychomotor. Environ Health Perspect 
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home during the third trimester of pregnancy, 
collecting information on demographics, race/
ethnicity, home characteristics and residential 
history, history of active and passive smoking, 
occupational history, marital status, educa-
tion and income level, prenatal alcohol and 
drug use, and maternal psychosocial condi-
tions. We also abstracted information from 
the mothers’ and infants’ medical records after 
delivery, including gestational age, infant sex, 
birth weight, length and head circumference, 
complications of pregnancy, medication use, 
and delivery method.
Urine sample collection and phthalate 
measurements. We collected a spot urine sam-
ple from the women during the third trimester 
of pregnancy (mean, 33.1 ± 3.0 weeks of gesta-
tion; median, 33 weeks). Samples were stored 
at Columbia University at –80°C, shipped 
to the CDC on dry ice, and stored at –70°C 
until analysis. The urinary phthalate metabo-
lite concentrations were measured at the CDC 
as previously described (Kato et al. 2005). 
Each analytical run included calibration stan-
dards, reagent blanks, and quality control 
samples. We used specific gravity to correct for 
urinary dilution as recommended for phtha-
lates (Hauser et al. 2004). Specific gravity 
was measured using a handheld refractometer 
(Atago PAL 10-S; Atago U.S.A. Inc., Bellevue, 
WA). As a measure of reliability, we calculated 
intraclass correlation coefficients (ICCs) for 
the phthalate metabolites in serial spot urine 
samples collected biweekly from 48 women 
in the CCCEH cohort over 6–8 weeks late in 
pregnancy (n = 135 samples, 2–4 repeats per 
woman). Adjusting for specific gravity, ICCs 
were 0.77 for MBzP, 0.65 for mono-n-butyl 
phthalate (MnBP), and 0.60 for monoisobutyl 
phthalate (MiBP) and ranged from 0.27 to 
0.42 for the DEHP metabolites.
Measures of child mental, psychomotor, and 
behavioral development. The BSID-II (Bayley 
1993) provides a developmental quotient (raw 
score/child chronologic age) from which a con-
tinuous Mental Development Index (MDI) 
and a Psychomotor Development Index (PDI) 
are generated. The raw scores are converted to a 
normalized scale with a mean of 100 and stan-
dard deviation of 15. Scores can be analyzed 
continuously (with higher scores indicating bet-
ter development), or children can be classified 
as normal or at risk of delay (scores ≤ 85). The 
child age at the administration of the BSID-II 
averaged 36.4 ± 1.7 (range, 27–42) months. 
Cohort children were tested under controlled 
conditions by trained bilingual research assis-
tants; interrater reliability has been previously 
described (Rauh et al. 2006). Behavioral prob-
lems were measured through maternal report 
of the 99-item CBCL for children 1.5–5 years 
of age, which provides an early indicator of 
potential behavioral problems in young chil-
dren (Achenbach 2000). The 99 items are 
summed into seven syndrome scales, with four 
scales (emotionally reactive, anxious/depressed, 
somatic complaints, withdrawn) subsequently 
summed into internalizing behaviors and two 
(attention and aggressive behaviors) summed 
into externalizing behaviors. The CBCL scales 
can be analyzed as continuous scores, or the 
children can be classified in the normal, bor-
derline, or clinical range based on predeter-
mined cut-points (Achenbach 2000). The child 
age at the administration of the CBCL aver-
aged 36.6 ± 2.8 (range, 33–48) months.
Model covariates. Prenatal psychosocial 
factors included maternal self-report of hard-
ship during pregnancy (lack of food, cloth-
ing, housing, gas or electricity, or medicines) 
and satisfaction with overall living condi-
tions. Maternal demoralization was measured 
by the 27-item Psychiatric Epidemiology 
Research Instrument-Demoralization Scale 
(Dohrenwend et al. 1978). Maternal intel-
ligence was assessed postnatally by the Test of 
Non-Verbal Intelligence, third edition (Brown 
et al. 1990), a 15-min, language-free meas-
ure of general intelligence, which is relatively 
stable and free of cultural bias. The quality of 
proximal care-taking environment was meas-
ured by the Caldwell and Bradley’s (1979) 
Home Observation for Measurement of the 
Environment (HOME) scale at child age 38.4 
± 6.2 months. Prenatal alcohol consumption 
and exposure to environmental tobacco smoke 
were measured by maternal self-report. Eight 
polycyclic aromatic hydrocarbons (PAHs) were 
quantified in 48-hr maternal third-trimester 
personal air samples and summed (Perera et al. 
2003). Bisphenol A (BPA) was measured in 
the maternal prenatal spot urine samples at 
CDC as previously described (Ye et al. 2005).
Statistical analysis. To examine the rela-
tionship between prenatal exposure to the four 
phthalates (assessed from the urinary metab-
olite concentrations) and BSID-III and/or 
CBCL outcomes, we used linear models for 
the continuous outcomes and logistic mod-
els for categorical outcomes. The few phtha-
late metabolite concentrations below the limit 
of detection (LOD) were assigned a value 
of LOD/2. Metabolite concentrations were 
right skewed and were transformed using the 
natural logarithm. From a pool of covariates 
known or suspected of being associated with 
the phthalate concentrations or BSID-II or 
CBCL outcomes (Eskenazi et al. 2007; Rauh 
et al. 2006; Wasserman et al. 2003; Whyatt 
et al. 2009), we selected those remaining sig-
nificant or marginally significant (p < 0.10) 
in the regression model for at least one of the 
outcome variables in the same set. Model cova-
riates for the BSID-II outcomes were child 
sex (boy vs. girl), race/ethnicity (Dominican 
vs. African American), the quality of proximal 
care-taking environment (continuous HOME 
scale), gestational age (in weeks), maternal 
marital status (never vs. ever married), maternal 
prenatal alcohol use (yes/no), and urine spe-
cific gravity. Maternal IQ was not controlled 
because it was not significant once the HOME 
scale had been added to the model and did 
not appreciably change the magnitude of the 
exposure–BSID-II outcome relationships. 
Covariates in the linear models for CBCL out-
comes were child age in months at the time of 
test administration, child sex, race/ethnicity, 
maternal IQ (categorized as described below), 
maternal satisfaction with overall living condi-
tions (yes/no), maternal perceived hardship 
(yes/no), maternal demoralization (continuous 
scale), maternal prenatal PAH exposure (cat-
egorized as described below), maternal prenatal 
urinary loge BPA concentrations, and specific 
gravity. Multinominal logistic regression was 
used to analyze the association between the 
urinary phthalate metabolite concentrations 
and whether the child fell in the normal, bor-
derline, or clinical range on the CBCL scales. 
The analyses were conducted only on the four 
scales that had at least 15 subjects (≥ 5% of 
the sample) in each cell. The control variables 
were child’s age in months at test administra-
tion, child sex, mother’s satisfaction, mater-
nal demoralization, and urine specific gravity. 
Urine specific gravity was standardized [(indi-
vidual subject value – mean value)/SD] before 
inclusion in all models. Additional variables 
assessed as confounders but not controlled were 
maternal education, prenatal environmental 
tobacco smoke, year and season of urine collec-
tion, and umbilical cord lead and chlorpyrifos. 
To evaluate whether language of test adminis-
trations (Spanish vs. English) acted as an effect 
modifier, we conducted stratified analyses 
and tested the interaction terms between the 
phthalate metabolites and language of admin-
istration; results were comparable to those 
presented here, and none of the interaction 
terms was significant. Missing values for the 
following five covari  ates were imputed: a) three 
missing values for maternal demoralization 
were imputed by a linear regression model 
with maternal education, maternal satisfaction, 
and maternal hardship as predictors (model 
R2 = 0.15, n = 285); b) 12 missing observa-
tions from the HOME scale were imputed by 
linear regres  sion with race/ethnicity, maternal 
education and IQ, and household income as 
predic  tors (model R2 = 0.18, n = 294); c) five 
missing observations for maternal hardship 
were imputed based on a logistic regression 
with race/ethnicity, maternal demoralization, 
maternal satisfaction, and prenatal PAH as pre-
dictors (model R2 = 0.18; n = 285); d) where 
there were > 5% of missing values (maternal 
IQ and PAH exposure), we categorized the 
observed data and added an additional cat-
egory for missing values. We excluded subjects 
with missing values for gestational age (n = 4) 
and BPA concentrations (n = 9), because these Whyatt et al.
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could not be imputed. We also conducted anal-
yses a) before imputation of the missing values 
and b) after removing subjects with very dilute 
urine (specific gravity < 1.007, n = 15) or con-
centrated urine (specific gravity > 1.03, n = 7); 
results were comparable to those presented here. 
Results from the linear models and the logistic 
model of BSID-II outcomes are presented for 
the total cohort and also after stratifying by 
child sex. Because of small sample sizes in at-
risk categories, logistic regression models were 
adjusted to remove covariates not significantly 
related to the outcome. Sex differences in the 
effect of the exposure variable were detected by 
the Wald test. Sample sizes were too small to 
stratify by child sex in the multinominal logistic 
regression analyses for CBCL outcomes. Results 
were considered significant at p < 0.05. Analyses 
were conducted using SAS (version 9.2; SAS 
Institute Inc., Cary, NC).
Results
Table 1 shows subject demographics and dis-
tributions of model covariates and outcome 
variables. Girls scored significantly higher 
than boys (p < 0.01, 2-group test) on both 
the mental (MDI scores, 93.1 ± 10.9 vs. 
88.8 ± 11.5) and psychomotor (PDI scores, 
101.4 ± 12.4 vs. 96.3 ± 14.3) scales, whereas 
boys had significantly higher scores than girls 
(p = 0.03) on attention problems (2.9 ± 2.1 
vs. 2.4 ± 1.8). There were no other signifi-
cant differences between boys and girls on the 
remaining scales (data not shown). Table 2 
shows the distribution of the urinary phtha-
late metabolite concentrations. Metabolites 
were detected in 84–100% of the urine sam-
ples. As expected, the four DEHP metabolite 
concentrations, adjusted for specific gravity, 
were highly correlated (Spearman’s correlation 
r-values ranged from 0.68 to 0.97) and were 
Table 1. Subject demographics, distribution of 
model covariates, and outcome variables (n = 319).
Characteristic Value
Maternal age (years) (n = 319) 25.5 ± 4.9
Ethnicity (n = 319)
African American 33.5
Dominican or other Hispanic 66.5
Maternal education (n = 319)
< High school degree 37.0
High school diploma or GED 36.7
> High school 26.3
Marital status (n = 319)
Never married 67.4
Marrieda 26.9
Separated, widowed, divorced 5.6
Household income (n = 295)
< $10,000 41.7
$10,000–$30,000 43.0
> $30,000 15.3
Maternal demoralization (n = 316) 1.1 ± 0.7
Maternal IQ (n = 291) 84.4 ± 13.2
Prenatal PAH in air (ng/m3) (n = 303) 3.4 ± 9.0
Prenatal BPA in urine (ng/mL) (n = 308) 3.2 ± 4.4
Maternal hardship (n = 313)b 43.1
Maternal satisfaction (% satisfied) (n = 319)c 27.0
Prenatal alcohol (n = 308)d 27.9
Child sex (% female) (n = 319) 52.7
HOME scale (n = 301) 39.3 ± 6.3
Outcome variables
BSID-II
MDI (n = 297) 91.3 ± 11.3
PDI (n = 296) 99.1 ± 13.6
CBCL (n = 286)
Emotionally reactive 1.9 ± 2.1
Anxious/depressed 3.2 ± 2.5
Somatic complaints 2.5 ± 2.4
Withdrawn behavior 2.0 ± 2.2
Sleep problems 2.8 ± 2.4
Attention problems 2.7 ± 1.9
Aggressive problems 10.1 ± 6.9
Internalizing behavior 9.5 ± 6.9
Externalizing behavior 12.8 ± 8.3
Values are mean ± SD or percent. 
aIncludes living with same partner for > 7 years. bLack of 
food, clothing, housing, gas or electricity, or medicines. 
cMaternal self-report of satisfaction with overall liv-
ing conditions. dReported drinking any alcohol during 
pregnancy.
Table 2. Distribution of phthalate metabolites (ng/mL) in maternal spot urine during the third trimester of 
pregnancy (n = 319).
Metabolite Percent > LODa Geometric mean (95% CI) Range
DEHP
Mono-2-ethylhexyl phthalate 84 5.1 (4.3, 6.0) < LOD to 613
Mono-(2-ethyl-5-hydroxyhexyl) phthalate 100 23.0 (20.1, 26.3) 1.1–1,750
Mono-(2-ethyl-5-oxohexyl) phthalate 100 19.2 (16.8, 22.0) 0.7–1,320
Mono-(2-ethyl-5-carboxypentyl) phthalate 100 40.2 (35.6, 45.4) 3.0–1,840
Non-DEHP
MBzP 99.7 19.0 (16.4, 22.0) < LOD to 1,110
MiBP 99.4 9.3 (8.3, 10.5) < LOD to 374
MnBP 100 38.0 (33.9, 42.6) 0.2–785
aLOD was 0.9–1.2 ng/mL for mono-2-ethylhexyl phthalate, 0.3–1.6 ng/ml for mono-(2-ethyl-5-hydoxyhexyl) phthalate, 
0.5–1.2 ng/mL for mono-(2-ethyl-5-oxohexyl) phthalate, 0.3–0.6 ng/mL for mono-(2-ethyl-5-carboxypentyl) phthalate, 
0.1–1.0 ng/ml for MBzP, 0.3–1.0 ng/mL for MiBP and 0.4–1.1 ng/mL for MnBP.
Table 3. Estimated coefficient of the predictor (maternal urinary phthalate metabolite concentrations) in 
the linear models for child MDI and PDI from the BSID-II.
β-Coefficient (95% CI) Child sex difference 
p-value Metabolite (loge) Total Girls Boys
PDI n = 296 n = 156 n = 140
MnBP –2.81 ( –4.63, –1.0)** –2.41 (–4.91, 0.08) –3.08 (–5.82, –0.33)* 0.72
MiBP –2.28 (–3.90, –0.67)** –2.33 (–4.59, – 0.08)* –2.21 (–4.61, 0.19) 0.94
MBzP –0.92 (–2.23, 0.40) –1.05 (–2.77, 0.67) –0.57 (–2.74, 1.60) 0.73
ΣDEHP 1.31 (–0.26, 2.89) 0.69 (–1.35, 2.73) 2.33 (–0.21, 4.87) 0.32
MDI n = 297 n = 157 n = 140
MnBP –1.12 (–2.62, 0.39) –2.67 (–4.70, –0.65)** 0.30 (–1.99, 2.59) 0.054
MiBP –0.28 (–1.62, 1.05) –1.33 (–3.20, 0.54) 0.59 (–1.40, 2.58) 0.16
MBzP –0.73 (–1.80, 0.34) –1.07 (–2.48, 0.33) –0.45 (–2.23, 1.32) 0.59
ΣDEHP 0.35 (–0.94, 1.64) –0.22 (–1.90, 1.46) 0.99 (–1.11, 3.09) 0.37
Sex difference was detected by Wald test. Models controlled for specific gravity, race/ethnicity, maternal marital status, 
maternal prenatal alcohol consumption, gestational age, the quality of proximal care-taking environment (HOME scale), 
and child sex (total analyses). 
*p < 0.05, **p ≤ 0.01.
Table 4. OR for child being at risk of mental or psychomotor delay (score ≤ 85) for each loge change in 
phthalate metabolite concentrations in maternal urine.
Metabolite (loge)
OR (95% CI) Sex difference 
p-value Total Girls Boys
PDI
n score ≤ 85/total n  52/296a 19/156b 33/140c
MnBP 1.64 (1.10, 2.44)* 1.57 (0.84, 2.94) 1.58 (0.95, 2.61) 0.99
MiBP 1.82 (1.24, 2.66)** 1.98 (1.02, 3.83)* 1.80 (1.13, 2.87)* 0.82
MBzP 1.08 (0.81, 1.44) 1.25 (0.80, 1.95) 0.96 (0.66, 1.39) 0.38
ΣDEHP 0.96 (0.68, 1.36) 1.13 (0.68, 1.87) 0.88 (0.56, 1.40) 0.48
MDI
n score ≤ 85/total n  83/297d 34/157e 49/140f
MnBP 0.93 (0.66, 1.31) 1.44 (0.84, 2.47) 0.68 (0.43, 1.07) 0.037
MiBP 0.89 (0.66, 1.20) 0.98 (0.62, 1.56) 0.87 (0.60, 1.28) 0.71
MBzP 0.89 (0.69, 1.15) 0.94 (0.66, 1.35) 0.89 (0.64, 1.25) 0.83
ΣDEHP 0.79 (0.58, 1.08) 0.95 (0.61, 1.47) 0.71 (0.45, 1.10) 0.35
All logistic regression models controlled for specific gravity. Sex difference was detected by Wald test.
aModels for PDI ≤ 85 also controlled for maternal marital status, gestational age, quality of proximal care-taking environ-
ment (HOME scale), and child sex. bModels for PDI ≤ 85 with girls also controlled for HOME scale. cModels for PDI ≤ 85 
with boys also controlled for HOME scale and maternal marital status. dModels for MDI ≤ 85 also controlled for race/
ethnicity, maternal marital status, maternal prenatal alcohol consumption, gestational age, HOME scale, and child sex. 
eModels for MDI ≤ 85 with girls also controlled for HOME scale and maternal prenatal alcohol consumption. fModels for 
MDI ≤ 85 with boys also controlled for race/ethnicity and gestational age. *p < 0.05, **p < 0.01.Prenatal phthalates and child development
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converted into their molecular weights and 
summed (ΣDEHP). The correlations between 
the DEHP and non-DEHP metabolite con-
centrations were weaker (r-values ranged from 
0.14 to 0.29). MnBP, MiBP, and mono-
benzyl phthalate (MBzP) concentrations were 
also correlated (r-values ranged from 0.42 to 
0.63), suggesting potential common exposure 
sources. There was no significant difference 
in the phthalate metabolites concentration in 
maternal urine during pregnancy by child sex 
(data not shown).
No significant associations were found 
between maternal concentrations of MBzP or 
ΣDEHP and child mental (MDI) or psycho-
motor (PDI) scores or mental or motor delay 
at 3 years of age (all p-values > 0.05; Tables 3 
and 4). We found a significant inverse asso-
ciation between loge MnBP [β = –2.81; 95% 
confidence interval (CI) –4.63, –1.0] and loge 
MiBP (β = –2.28; 95% CI: –3.90, –0.67) con-
centrations and child PDI (Table 3). Among 
girls, loge MnBP concentrations were associ-
ated with decreases in child MDI (β = –2.67; 
95% CI: –4.70, –0.65). The odds of psycho-
motor delay (scores ≤ 85) increased with con-
centrations of loge MnBP [odds ratio (OR) 
= 1.64; 95% CI: 1.10, 2.44] and loge MiBP 
(OR = 1.82; 95% CI: 1.24, 2.66) (Table 4). 
There were no significant child sex differences 
in associations between the phthalates and 
motor delay. There was a significant child sex 
difference between loge MnBP and the risk of 
mental delay (p = 0.037; Table 4).
No significant associations were found 
between ΣDEHP metabolite concentra-
tions and any CBCL outcome (all p-values 
> 0.05; Tables 5 and 6). None of the phtha-
late metabolite concentrations were associ-
ated with child sleep problems or with scales 
in the externalizing domains (all p-values 
> 0.05; data not shown). Among the total 
cohort, loge MnBP concentrations were sig-
nificantly associated with increases in somatic 
complaints (β = 0.54; 95% CI: 0.19, 0.90), 
withdrawn behavior (β = 0.40; 95% CI: 0.05, 
0.74), and internalizing behaviors (β = 1.45; 
95% CI: 0.40, 2.50) (Table 5). Loge MiBP 
concentrations were significantly associated 
with increases in emotionally reactive behav-
ior (β = 0.32; 95% CI: 0.01, 0.62). Loge 
MBzP concentrations were associated with 
significant increases in withdrawn behavior 
(β = 0.31; 95% CI: 0.07, 0.55) and inter-
nalizing behaviors (β = 0.83; 95% CI: 0.11, 
1.56). Associations between phthalate con-
centrations and internalizing behaviors varied 
somewhat by child sex. Among boys only, 
loge MnBP concentrations were significantly 
associated with emotionally reactive behav-
ior, somatic complaints, withdrawn behavior, 
and internalizing behaviors (Table 5). Among 
girls only, loge MBzP concentrations were sig-
nificantly associated with anxious/depressed 
behavior, somatic complaints, withdrawn 
behavior, and internalizing behaviors. The 
child sex difference was significant for MnBP 
on emotionally reactive behavior (p = 0.03) 
and for MBzP on anxious depressed behavior 
(p = 0.035), somatic complaints (p = 0.01), 
and internalizing behaviors (p = 0.04), but 
not for the other scales (p-values ranged from 
0.12 to 0.99; Table 5).
Table 6 shows estimated ORs for expo-
sure and scores on the borderline and clini-
cal ranges on the CBCL. We observed 
significantly increased ORs for the association 
between MnBP and MBzP concentrations 
and scores in the clinical range for withdrawn 
behavior (for each log unit increase, respec-
tively: OR = 2.23; 95% CI: 1.27, 3.92; and 
OR = 1.57; 95% CI: 1.07, 2.31). Finally, we 
found increased ORs per log unit increase for 
scoring in the borderline range for internaliz-
ing behaviors related to MiBP concentrations 
(OR = 1.98; 95% CI: 1.24, 3.23) and MBzP 
concentrations (OR = 1.38; 95% CI: 1.01, 
1.90) and for scoring in the clinical range on 
internalizing behaviors related to MBzP con-
centrations (OR = 1.43; 95% CI: 1.01, 1.90). 
Table 5. Estimated coefficient of the predictor (maternal urine phthalate concentrations) in the linear 
models for internalizing behaviors on the CBCL when children were 3 years of age.
Behavior/metabolite (loge)
β-Coefficient (95% CI) Sex difference 
p-value Total cohort (n = 277) Girls (n = 148)  Boys (n = 129) 
Emotionally reactive
MnBP 0.25 (–0.09, 0.58) –0.02 (–0.50, 0.45) 0.71 (0.22, 1.19)** 0.03
MiBP 0.32 (0.01, 0.62)* 0.34 (–0.11, 0.78) 0.42 (–0.005, 0.85) 0.79
MBzP 0.21 (–0.02, 0.44) 0.26 (–0.05, 0.57) 0.34 (–0.008, 0.69) 0.72
ΣDEHP –0.0002 (–0.27, 0.27) 0.07 (–0.30, 0.44) –0.007 (–0.5, 0.4) 0.79
Anxious/depressed
MnBP 0.26 (–0.11, 0.65) 0.41 (–0.11, 0.94) 0.17 (–0.40, 0.75) 0.54
MiBP 0.12 (–0.23, 0.47) 0.16 (–0.34, 0.66) 0.12 (–0.38, 0.61) 0.91
MBzP 0.22 (–0.04, 0.48) 0.51 (0.17, 0.85)** –0.05 (–0.46, 0.35) 0.035
ΣDEHP 0.18 (–0.13, 0.49) 0.18 (–0.23, 0.59) 0.19 (–0.32, 0.70) 0.98
Somatic complaints
MnBP 0.54 (0.19, 0.90)** 0.43 (–0.06, 0.91) 0.77 (0.21, 1.33)** 0.35
MiBP 0.25 (–0.08, 0.58) 0.24 (–0.22, 0.70) 0.31 (–0.18, 0.81) 0.83
MBzP 0.09 (–0.15, 0.34) 0.42 (0.10, 0.73)** –0.23 (–0.63, 0.17) 0.01
ΣDEHP –0.06 (–0.35, 0.23) –0.08 (–0.45, 0.30) –0.12 (–0.62, 0.39) 0.90
Withdrawn behavior
MnBP 0.40 (0.05, 0.74)* 0.47 (–0.03, 0.98) 0.56 (0.09, 1.03)* 0.79
MiBP 0.28 (–0.04, 0.60) 0.47 (–0.007, 0.94) 0.36 (–0.05, 0.77) 0.74
MBzP 0.31 (0.07, 0.55)** 0.61 (0.29, 0.93)# 0.24 (–0.09, 0.58) 0.12
ΣDEHP –0.04 (–0.32, 0.25) –0.04 (–0.44, 0.36) 0.15 (–0.28, 0.57) 0.52
Internalizing behavior
MnBP 1.45 (0.40, 2.50)** 1.29 (–0.15, 2.72) 2.21 (0.66, 3.76)** 0.39
MiBP 0.97 (–0.002, 1.94) 1.20 (–0.15, 2.55) 1.21 (–0.16, 2.56) 0.99
MBzP 0.83 (0.11, 1.56)* 1.79 (0.88, 2.69)** 0.29 ( –0.83, 1.42) 0.04
ΣDEHP 0.08 (–0.78, 0.95) 0.13 (–0.99, 1.26) 0.21 (–1.21, 1.63) 0.93
Sex difference was detected by Wald test. Models controlled for ethnicity, maternal IQ, maternal demoralization, mater-
nal hardship and maternal satisfaction during pregnancy, maternal prenatal exposure to PAH and BPA, child sex, child 
age in months at the time of the CBCL administration, and specific gravity. 
*p < 0.05, **p ≤ 0.01, #p < 0.001.
Table 6. OR (95% CI) for child scoring in the borderline or clinical compared with normal range on inter-
nalizing behaviors for each loge unit increase in maternal phthalate metabolite concentrations (n = 286).
Behavior/metabolite (loge) Borderline Clinical
Somatic complaints n = 35 n = 18
MnBP 1.32 (0.84, 2.08) 1.37 (0.73, 2.56)
MiBP 1.29 (0.84, 1.99) 0.76 (0.42, 1.36)
MBzP 0.83 (0.59, 1.15) 1.20 (0.78, 1.86)
ΣDEHP 0.88 (0.58, 1.33) 0.96 (0.57, 1.61)
Withdrawn behavior n = 15 n = 23
MnBP 0.60 (0.31, 1.16) 2.23 (1.27, 3.92)**
MiBP 0.81 (0.44, 1.51) 1.62 (0.97, 2.73)
MBzP 0.79 (0.48, 1.28) 1.57 (1.07, 2.31)*
ΣDEHP 0.67 (0.35, 1.30) 0.98 (0.62, 1.55)
Internalizing behavior n = 31 n = 37
MnBP 1.31 (0.82, 2.10) 1.44 (0.92, 2.25)
MiBP 1.98 (1.24, 3.23)** 1.41 (0.91, 2.18)
MBzP 1.38 (1.01, 1.90)* 1.43 (1.01, 1.90)*
ΣDEHP 1.26 (0.85, 1.86) 1.19 (0.82, 1.72)
Models controlled for maternal demoralization and maternal satisfaction during pregnancy, child sex, child age in 
months at the time of the CBCL administration, and specific gravity. 
*p < 0.05, **p ≤ 0.01.Whyatt et al.
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Discussion
This is one of the few epidemiologic studies 
to estimate effects of prenatal phthalate expo-
sures on child cognitive and behavioral devel-
opment and, to our knowledge, is the only 
study to look at these associations during the 
preschool years. MnBP and MiBP metabolite 
concentrations during pregnancy were signifi-
cantly associated with decreases in psychomo-
tor development and with increased odds of 
psychomotor delay. In girls, but not boys, 
maternal prenatal MnBP was also associated 
with a significant decrease in the child’s mental 
development at 3 years of age. Further, MnBP, 
MiBP, and MBzP were significantly associated 
with increases in a number of behavioral prob-
lems in the internalizing domains and increased 
odds that the child would score in the clini-
cal range. Geometric mean concentrations of 
the phthalate metabolites measured here were 
1.3–2.7 times higher than in a representative 
sample of pregnant U.S. women sampled in 
2003–2004 (Woodruff et al. 2011).
In addition to our study, Engel et al. 
(2010) evaluated associations between prena-
tal phthalate metabolite concentrations and 
outcomes on the Behavioral Rating Inventory 
of Executive Function and the Behavior 
Assessment System for Children-Parent 
Rating Scales (BASC-PRS) when children 
were 4–9 years of age (n = 171). The metabo-
lites were divided into high-molecular-weight 
phthalates (HMWPs; predominantly DEHP 
metabolites) and low-molecular-weight phtha-
lates (LMWPs; including MnBP, MiBP). No 
significant associations were found between 
urinary concentrations of the HMWP metabo-
lites and most of the outcomes, except for 
adaptability. However, urinary concentrations 
of LMWPs were significantly associated with 
poorer scores on aggression, attention, con-
duct problems, depression, and externalizing 
problems. Most of these associations were spe-
cific to boys. LMWP concentrations were also 
positively associated with poorer scores on the 
global executive composite index and emo-
tional control scale, as well as social cognition, 
social communication, and social awareness 
(Miodovnik et al. 2011). A second longitudi-
nal birth cohort study by Swan et al. (2010) 
evaluated associations between maternal pre-
natal phthalate metabolite concentrations and 
behavior in children 3.6–6 years of age (n = 
145) on the Pre-School Activities Inventory, a 
validated instrument to assess sexually dimor-
phic play behavior. MnBP, MiBP, and the 
DEHP metabolite concentrations were associ-
ated with less masculine play behavior among 
boys. Two cross-sectional studies reported 
that DEHP and/or DnBP metabolites in child 
urine were positively associated with behav-
ioral problems and inversely associated with 
IQ among Korean children (Cho et al. 2010; 
Kim et al. 2009). Comparisons of these results 
to our findings are challenging because study 
designs, metabolite concentrations, and out-
come measures differed and the children were 
evaluated at different ages. The latter could be 
particularly important because parents’ aware-
ness of the internal states of their children may 
vary between school-age and younger children. 
However, significant correlations between 
anxious/depressed, somatic complaints, and 
withdrawn and internalizing behaviors by 
parental report on the CBCL and depression 
and attention problems by parental report on 
the BASC-PRS have been seen among both 
preschoolers and older children (Doyle et al. 
1997; Reynolds and Kamphaur 1992), provid-
ing evidence of some comparability between 
our findings and those of Engel et al. (2010) 
discussed above.
Experimental studies in laboratory rodents 
are similarly limited but have found significant 
associations between prenatal DEHP exposure 
and significant increases in time to perform 
the beam walking test (Arcadi et al. 1998), 
decrease in surface righting, and acceleration 
in the swimming direction tests (Tanaka 2002, 
2005); and between prenatal DnBP exposure 
and depressed surface righting, shortened fore-
paw grip time, and inhibition in spatial learn-
ing and memory at low doses, but enhanced 
spatial learning and memory at high doses. Sex 
× treatment effects were seen for a number of 
domains, and males appeared to be more sen-
sitive (Li et al. 2009).
In terms of potential mechanism, associa-
tions between exposures to DEHP, DnBP, 
and BBzP and modulation of thyroid function 
or reductions in circulating thyroid hormone 
levels have been seen in experimental stud-
ies (Breous et al. 2005; Hinton et al. 1986; 
Howarth et al. 2001; O’Connor et al. 2002; 
Pereira et al. 2007; Poon et al. 1997; Price 
et al. 1998; Sugiyama et al. 2005), as well as 
several epidemiologic studies (Boas et al. 2010; 
Huang et al. 2007; Meeker and Ferguson 
2011; Meeker et al. 2007), and could be one 
mechanism given the critical role that thyroid 
hormone plays in fetal and early postnatal brain 
development (Attree et al. 1992; Hendrich 
et al. 1984; Porterfield and Hendrich 1993). 
Furthermore, modulation of testosterone pro-
duction by phthalates in the male fetus could 
be another potential mechanism whereby the 
compounds could disrupt sexually dimorphic 
behaviors. Experimental data have established 
that DnBP, DiBP, BBzP, and DEHP are all 
equally potent at inhibiting testosterone pro-
duction in male rats during fetal development 
(Howdeshell et al. 2008) and that this disrup-
tion results in abnormalities in genital develop-
ment (Swan 2008). However, testosterone also 
plays a critical role in male brain development. 
Testosterone synthesized by the testis diffuses 
into the brain, where it is converted to estradiol 
by aromatase in specific male brain regions 
(Roselli et al. 2009). The estradiol is thought 
to organize the brain along a masculine phe-
notype, with resultant male sexual behaviors 
(Wu et al. 2009). Reduction of testosterone 
production by phthalates during fetal develop-
ment has been hypothesized as a mechanism 
for the feminization in play behavior observed 
among boys (Swan et al. 2010). Preliminary 
data also suggest that phthalates can modulate 
aromatase activity itself, and this could be yet 
a third potential mechanism affecting brain 
development. Estradiol is synthesized de novo 
in both male and female brains from choles-
terol, a reaction catalyzed by aromatase, and is 
essential for brain development in both sexes 
(Bakker and Brock 2010; McCarthy 2009; 
Roselli et al. 2009). Only one prior experimen-
tal study has shown a link between phthalate 
exposure and modulations of aromatase activity 
in the developing brain (Andrade et al. 2006). 
Phthalates have also been shown to modulate 
aromatase activity or expression in other tissues 
(Adibi et al. 2010; Lovekamp-Swan and Davis 
2003). Finally, experimental studies suggest 
that prenatal DEHP exposure alters transfer 
of essential fatty acids across the placenta and 
decreases lipid content in fetal brains. This 
could be another mechanism whereby phtha-
late exposure might alter brain development 
(Xu et al. 2007, 2008).
In addition to the uncertainty over potential 
mechanisms whereby prenatal phthalate expo-
sure might be affecting child mental, motor, or 
behavior development, additional limitations 
in our study results should be noted. In par-
ticular, whereas prior results, as well as our own 
study findings, suggest that phthalate–outcome 
relationships are likely to be sexually dimor-
phic, mechanistic understanding of the child 
sex × phthalate interactions is in its infancy. 
It is certainly possible that mothers are more 
likely to be concerned about, and thus report, 
internalizing behaviors in boys compared with 
girls. However, reporting bias is unlikely to 
have influenced our results because MnBP was 
associated with internalizing behaviors in boys 
but not in girls, whereas MBzP was associated 
with internalizing behaviors in girls but not 
boys, and a number of the child sex differences 
were statistically significant. More important, 
assessment of mental, motor, and behavioral 
development during the preschool years is chal-
lenging (Burchinal et al. 2000; Sternberg et al. 
2001). Our findings may also be compromised 
by the reliability of the biomarkers used to char-
acterize DEHP exposure, because the ICCs in 
repeat urine samples were lower for the DEHP 
metabolites than for metabolites of the other 
three phthalates examined. Moreover, prior epi-
demiologic studies are extremely limited, and 
none has estimated effects of prenatal phthalate 
exposure on these outcomes during the pre-
school years, making the comparison of our 
findings to the prior results difficult.Prenatal phthalates and child development
Environmental Health Perspectives  •  v o l u m e  120 | n u m b e r 2 | February 2012  295
Conclusion
Results presented here suggest that prenatal 
exposure to DnBP, DiBP, and BBzP may 
adversely affect child mental, motor, and 
behavioral development during the preschool 
years. These findings raise a public health con-
cern but, given the limitations discussed above, 
should be interpreted with caution, and addi-
tional research is warranted. This is especially 
true in light of recent epidemiologic findings 
among elementary school-age children show-
ing significant negative correlations between 
internalizing behaviors (anxious/depressed and 
withdrawn symptoms) on the CBCL and intel-
lectual function, language, visual construction 
skills, attention, processing speed, executive 
function, aspects of learning and memory, psy-
chomotor coordination, and basic academic 
skills (Lundy et al. 2010). We will continue to 
follow children in the present cohort to assess 
associations between prenatal as well as post-
natal phthalate exposures and child mental, 
motor, and behavioral development during the 
elementary school years.
RefeRences
Achenbach TM. 2000. Manual for the ASEBA Preschool 
Forms and Profiles: Child Behavior Checklist Ages 1.5–5. 
Burlington, VT:University of Vermont, Research Center for 
Children, Youth and Families.
Adibi JJ, Whyatt RM, Hauser R, Bhat HK, Davis BJ, Calafat AM, 
et al. 2010. Transcriptional biomarkers of steroidogenesis 
and trophoblast differentiation in the placenta in relation 
to prenatal phthalate exposure. Environ Health Perspect 
118:291–296.
Andrade AJ, Grande SW, Talsness CE, Gericke C, Grote K, 
Golombiewski A, et al. 2006. A dose response study follow-
ing in utero and lactational exposure to di-(2-ethylhexyl) 
phthalate (DEHP): reproductive effects on adult male off-
spring rats. Toxicology 228(1):85–97.
Arcadi FA, Costa C, Imperatore C, Marchese A, Rapisarda A, 
Salemi M, et al. 1998. Oral toxicity of bis(2-ethylhexyl) 
phthalate during pregnancy and suckling in the Long-
Evans rat. Food Chem Toxicol 36(11):963–970.
Attree EA, Sinha AK, Davey MJ, Pickard MR, Rose FD, Ekins RP. 
1992. Effects of maternal hypothyroxinaemia on activity, 
emotional responsiveness and exploratory behaviour in 
adult rat progeny. Med Sci Res 20(5):197–199.
Bakker J, Brock O. 2010. Early oestrogens in shaping reproduc-
tive networks: evidence for a potential organisational role of 
oestradiol in female brain development. J Neuroendocrinol 
22:728–735.
Bayley N. 1993. Bayley Scales of Infant Development. 2nd ed. 
San Antonio, TX:Psychological Corporation.
Boas M, Frederiksen H, Feldt-Rasmussen UF, Skakkebaek NE, 
Hegedus L, Hilsted, L, et al. 2010. Childhood exposure to 
phthalates: association with thyroid function, insulin-like 
growth factor I, and growth. Environ Health Perspect 
118:1458–1464.
Breous E, Wenzel A, Loos U. 2005. The promoter of the human 
sodium/iodide symporter responds to certain phthalate 
plasticisers. Mol Cell Endocrinol 244(1–2):75–78.
Brown L, Sherbenou RJ, Johnson SK. 1990. Test of Non-Verbal 
Intelligence: A Language-Free Measure of Cognitive 
Ability. Austin, TX:PRO-ED.
Burchinal MR, Roberts JE, Riggin R Jr, Zeisel SA, Neebe E, 
Bryant D. 2000. Relating quality of center-based child care 
to early cognitive and language development longitudi-
nally. Child Dev 71(2):339–357.
Caldwell BM, Bradley RH. 1979. Home Observation for 
Measurement of the Environment. Little Rock:University 
of Arkansas Press.
CDC (Centers for Disease Control and Prevention). 2011. Fourth 
National Report on Human Exposure to Environmental 
Chemicals, Updated Tables, February 2011. Atlanta, 
GA:CDC. Available: http://www.cdc.gov/exposurereport/
pdf/Updated_Tables.pdf [accessed 25 February 2011].
Cho SC, Bhang SY, Hong YC, Shin MS, Kim BN, Kim JW, et al. 
2010. Relationship between environmental phthalate expo-
sure and the intelligence of school-age children. Environ 
Health Perspect 118:1027–1032.
Dohrenwend BS, Krasnoff L, Askenasy AR, Dohrenwend 
BP. 1978. Exemplification of a method for scaling life 
events: the Peri Life Events Scale. J Health Soc Behav 
19(2):205–229.
Doyle A, Ostrander R, Skare S, Crosby RD, August GJ. 1997. 
Convergent and criterion-related validity of the Behavior 
Assessment System for Children-Parent Rating Scale. 
J Clin Child Psychol 26(3):276–284.
Engel SM, Miodovnik A, Canfield RL, Zhu C, Silva MJ, 
Calafat AM, et al. 2010. Prenatal phthalate exposure is 
associated with childhood behavior and executive func-
tioning. Environ Health Perspect 118:565–571.
Eskenazi B, Marks AR, Bradman A, Harley K, Barr DB, 
Johnson C, et al. 2007. Organophosphate pesticide expo-
sure and neurodevelopment in young Mexican-American 
children. Environ Health Perspect 115:792–798.
Hauser R, Meeker JD, Park S, Silva MJ, Calafat AM. 2004. 
Temporal variability of urinary phthalate metabolite lev-
els in men of reproductive age. Environ Health Perspect 
112:1734–1740.
Hendrich CE, Jackson WJ, Porterfield SP. 1984. Behavioral 
testing of progenies of Tx (hypothyroid) and growth hor-
mone-treated Tx rats: an animal model for mental retarda-
tion. Neuroendocrinology 38(6):429–437.
Heudorf  U,  Mersch-Sundermann  V,  Angerer  J.  2007. 
Phthalates: toxicology and exposure. Int J Hyg Environ 
Health 210(5):623–634.
Hinton RH, Mitchell FE, Mann A, Chescoe D, Price SC, Nunn A, 
et al. 1986. Effects of phthalic acid esters on the liver and 
thyroid. Environ Health Perspect 70:195–210.
Howarth JA, Price SC, Dobrota M, Kentish PA, Hinton RH. 2001. 
Effects on male rats of di-(2-ethylhexyl) phthalate and 
di-n-hexylphthalate administered alone or in combination. 
Toxicol Lett 121(1):35–43.
Howdeshell KL, Wilson VS, Furr J, Lambright CR, Rider CV, 
Blystone CR, et al. 2008. A mixture of five phthalate esters 
inhibits fetal testicular testosterone production in the 
Sprague Dawley rat in a cummulative, dose additive man-
ner. Toxicol Sci 105:153–165.
Huang PC, Kuo PL, Guo YL, Liao PC, Lee CC. 2007. Associations 
between urinary phthalate monoesters and thyroid hor-
mones in pregnant women. Hum Reprod 22(10):2715–2722.
Kato K, Silva MJ, Needham LL, Calafat AM. 2005. Determination 
of 16 phthalate metabolites in urine using automated sam-
ple preparation and on-line preconcentration/high-perfor-
mance liquid chromatography/tandem mass spectrometry. 
Anal Chem 77(9):2985–2991.
Kim BN, Cho SC, Kim Y, Shin MS, Yoo HJ, Kim JW, et al. 
2009. Phthalates exposure and attention-deficit/hyper-
activity disorder in school-age children. Biol Psychiatry 
66(10):958–963.
Li Y, Zhuang M, Li T, Shi N. 2009. Neurobehavioral toxicity study 
of dibutyl phthalate on rats following in utero and lacta-
tional exposure. J Appl Toxicol 29(7):603–611.
Lovekamp-Swan T, Davis BJ. 2003. Mechanisms of phthalate 
ester toxicity in the female reproductive system. Environ 
Health Perspect 111:139–145.
Lundy SM, Silva GE, Kaemingk KL, Goodwin JL, Quan SF. 
2010. Cognitive functioning and academic performance in 
elementary school children with anxious/depressed and 
withdrawn symptoms. Open Pediatr Med Journal 4:1–9.
McCarthy MM. 2009. The two faces of estradiol: effects on the 
developing brain. Neuroscientist 15(6):599–610.
Meeker JD, Calafat AM, Hauser R. 2007. Di(2-ethylhexyl) phtha-
late metabolites may alter thyroid hormone levels in men. 
Environ Health Perspect 115:1029–1034.
Meeker JD, Ferguson KK. 2011. Relationship between urinary 
phthalate and bisphenol A concentrations and serum 
thyroid measures in U.S. adults and adolescents from the 
National Health and Nutrition Examination Survey (NHANES) 
2007–2008. Environ Health Perspect 119:1396–1402. 
Miodovnik A, Engel SM, Zhu C, Ye X, Soorya LV, Silva MJ, et al. 
2011. Endocrine disruptors and childhood social impair-
ment. Neurotoxicology 32:261–267.
O’Connor JC, Frame SR, Ladics GS. 2002. Evaluation of a 15-day 
screening assay using intact male rats for identifying anti-
androgens. Toxicol Sci 69(1):92–108.
Pereira C, Mapuskar K, Vaman Rao C. 2007. A two-generation 
chronic mixture toxicity study of Clophen A60 and diethyl 
phthalate on histology of adrenal cortex and thyroid of 
rats. Acta Histochem 109(1):29–36.
Perera FP, Rauh V, Tsai WY, Kinney P, Camann D, Barr D, et al. 
2003. Effects of transplacental exposure to environmental 
pollutants on birth outcomes in a multiethnic population. 
Environ Health Perspect 111:201–205.
Poon R, Lecavalier P, Mueller R, Valli VE, Procter BG, Chu I. 
1997. Subchronic oral toxicity of di-n-octyl phthalate and 
di(2-ethylhexyl) phthalate in the rat. Food Chem Toxicol 
35(2):225–239.
Porterfield SP, Hendrich CE. 1993. The role of thyroid hormones 
in prenatal and neonatal neurological development—
current perspectives. Endocr Rev 14(1):94–106.
Price SC, Chescoe D, Grasso P, Wright M, Hinton RH. 1998. 
Alterations in the thyroids of rats treated for long periods 
with di-(2-ethylhexyl) phthalate or with hypolipidaemic 
agents. Toxicol Lett 40(1):37–46.
Rauh VA, Garfinkel R, Perera FP, Andrews HF, Hoepner L, 
Barr DB, et al. 2006. Impact of prenatal chlorpyrifos expo-
sure on neurodevelopment in the first 3 years of life among 
inner-city children. Pediatrics 118(6):e1845–e1859.
Reynolds C, Kamphaur, RW. 1992. Behavior Assessment 
System for Children: Manual. Circle Pines, MN:American 
Guidance Service, Inc.
Roselli CE, Liu M, Hurn PD. 2009. Brain aromatization: classic roles 
and new perspectives. Semin Reprod Med 27(3):207–217.
Sathyanarayana S. 2008. Phthalates and children’s health. Curr 
Probl Pediatr Adolesc Health Care 38(2):34–49.
Sternberg RJ, Grigorenko E, Bundy DA. 2011. The predictive 
power of IQ. Merrill-Palmer Q 47:1–41.
Sugiyama S, Shimada N, Miyoshi H, Yamauchi K. 2005. 
Detection of thyroid system-disrupting chemicals using 
in vitro and in vivo screening assays in Xenopus laevis. 
Toxicol Sci 88(2):367–374.
Swan SH. 2008. Environmental phthalate exposure in relation 
to reproductive outcomes and other health endpoints in 
humans. Environ Res 108(2):177–184.
Swan SH, Liu F, Hines M, Kruse RL, Wang C, Redmon JB, et al. 
2010. Prenatal phthalate exposure and reduced masculine 
play in boys. Int J Androl 33(2):259–269.
Tanaka T. 2002. Reproductive and neurobehavioural toxicity 
study of bis(2-ethylhexyl) phthalate (DEHP) administered 
to mice in the diet. Food Chem Toxicol 40(10):1499–1506.
Tanaka T. 2005. Reproductive and neurobehavioural effects of 
bis(2-ethylhexyl) phthalate (DEHP) in a cross-mating toxic-
ity study of mice. Food Chem Toxicol 43(4):581–589.
Wasserman GA, Factor-Litvak P, Liu X, Todd AC, Kline JK, 
Slavkovich V, et al. 2003. The relationship between blood 
lead, bone lead and child intelligence. Child Neuropsychol 
9(1):22–34.
Whyatt RM, Adibi JJ, Calafat AM, Camann DE, Rauh V, Bhat HK, 
et al. 2009. Prenatal di(2-ethylhexyl) phthalate exposure in 
relation to length of gestation among a cohort of inner-city 
cohort. Pediatrics 124(6):e1213–e1220.
Wittassek M, Angerer J. 2008. Phthalates: metabolism and 
exposure. Int J Androl 31(2):131–138.
Woodruff T, Zota AR, Schwartz JM. 2011. Environmental chemi-
cals in pregnant women in the United States: NHANES 
2003–2004. Environ Health Perspect 119:878–885.
Wu MV, Manoli DS, Fraser EJ, Coats JK, Tollkuhn J, Honda S, 
et al. 2009. Estrogen masculinizes neural pathways and 
sex-specific behaviors. Cell 139(1):61–72.
Xu Y, Agrawal S, Cook TJ, Knipp GT. 2007. Di-(2-ethylhexyl)-
phthalate affects lipid profiling in fetal rat brain upon 
maternal exposure. Arch Toxicol 81(1):57–62.
Xu Y, Agrawal S, Cook TJ, Knipp GT. 2008. Maternal di-(2-
ethylhexyl)-phthalate exposure influences essential fatty 
acid homeostasis in rat placenta. Placenta 29(11):962–969.
Ye X, Kuklenyik Z, Needham LL, Calafat AM. 2005. Automated 
on-line column-switching HPLC-MS/MS method with peak 
focusing for the determination of nine environmental phe-
nols in urine. Anal Chem 77(16):5407–5413.